Profiles

Keywords
Last Name
Institution

Sheila Dowd

TitleAssociate Professor
InstitutionRush University, Rush Medical College
DepartmentPsychiatry
Address
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    My Scopus ID is 7101645788.
    My NIH COMMONS name is SDOWD1.


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Smits JAJ, Pollack MH, Rosenfield D, Otto MW, Dowd S, Carpenter J, Dutcher CD, Lewis EM, Witcraft SM, Papini S, Curtiss J, Andrews L, Kind S, Conroy K, Hofmann SG. Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2020 Jun 01; 3(6):e206777. PMID: 32496566.
      View in: PubMed
    2. Dowd SM, Zalta AK, Burgess HJ, Adkins EC, Valdespino-Hayden Z, Pollack MH. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World J Psychiatry. 2020 Mar 19; 10(3):21-28. PMID: 32257848.
      View in: PubMed
    3. Hofmann SG, Papini S, Carpenter JK, Otto MW, Rosenfield D, Dutcher CD, Dowd S, Lewis M, Witcraft S, Pollack MH, Smits JAJ. Effect of d-cycloserine on fear extinction training in adults with social anxiety disorder. PLoS One. 2019; 14(10):e0223729. PMID: 31622374.
      View in: PubMed
    4. Otto MW, Pollack MH, Dowd SM, Hofmann SG, Pearlson G, Szuhany KL, Gueorguieva R, Krystal JH, Simon NM, Tolin DF. RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER. Depress Anxiety. 2016 08; 33(8):737-45. PMID: 27315514.
      View in: PubMed
    5. Philip NS, Dunner DL, Dowd SM, Aaronson ST, Brock DG, Carpenter LL, Demitrack MA, Hovav S, Janicak PG, George MS. Erratum to "Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study" [Brain Stimulation 9 (2016) 251-257]. Brain Stimul. 2016 Jul-Aug; 9(4):639. PMID: 27320180.
      View in: PubMed
    6. Philip NS, Dunner DL, Dowd SM, Aaronson ST, Brock DG, Carpenter LL, Demitrack MA, Hovav S, Janicak PG, George MS. Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study. Brain Stimul. 2016 Mar-Apr; 9(2):251-7. PMID: 26708778.
      View in: PubMed
    7. Zalta AK, Dowd S, Rosenfield D, Smits JA, Otto MW, Simon NM, Meuret AE, Marques L, Hofmann SG, Pollack MH. Sleep quality predicts treatment outcome in CBT for social anxiety disorder. Depress Anxiety. 2013 Nov; 30(11):1114-20. PMID: 24038728.
      View in: PubMed
    8. Wall CA, Croarkin PE, Sim LA, Husain MM, Janicak PG, Kozel FA, Emslie GJ, Dowd SM, Sampson SM. Adjunctive use of repetitive transcranial magnetic stimulation in depressed adolescents: a prospective, open pilot study. J Clin Psychiatry. 2011 Sep; 72(9):1263-9. PMID: 21951987.
      View in: PubMed
    9. Janicak PG, Nahas Z, Lisanby SH, Solvason HB, Sampson SM, McDonald WM, Marangell LB, Rosenquist P, McCall WV, Kimball J, O'Reardon JP, Loo C, Husain MH, Krystal A, Gilmer W, Dowd SM, Demitrack MA, Schatzberg AF. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul. 2010 Oct; 3(4):187-99. PMID: 20965447.
      View in: PubMed
    10. Janicak PG, Dowd S, Rado J, Welch MJ, Fogg L, O'Reardon J, Avery D, Coffey CE, Sampson S, Boutros N. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy: efficacy of treatment in nonpsychotic patients with depression. Am J Psychiatry. 2007 Jul; 164(7):1118; author reply 1118-9. PMID: 17606665.
      View in: PubMed
    11. Negrusz A, Bowen AM, Moore CM, Dowd SM, Strong MJ, Janicak PG. Elimination of 7-aminoclonazepam in urine after a single dose of clonazepam. Anal Bioanal Chem. 2003 Aug; 376(8):1198-204. PMID: 12845398.
      View in: PubMed
    12. Martis B, Alam D, Dowd SM, Hill SK, Sharma RP, Rosen C, Pliskin N, Martin E, Carson V, Janicak PG. Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression. Clin Neurophysiol. 2003 Jun; 114(6):1125-32. PMID: 12804681.
      View in: PubMed
    13. Negrusz A, Bowen AM, Moore CM, Dowd SM, Strong MJ, Janicak PG. Deposition of 7-aminoclonazepam and clonazepam in hair following a single dose of Klonopin. J Anal Toxicol. 2002 Oct; 26(7):471-8. PMID: 12423002.
      View in: PubMed
    14. Dowd SM, Strong MJ, Janicak PG, Negrusz A. The behavioral and cognitive effects of two benzodiazepines associated with drug-facilitated sexual assault. J Forensic Sci. 2002 Sep; 47(5):1101-7. PMID: 12353555.
      View in: PubMed
    15. Janicak PG, Dowd SM, Martis B, Alam D, Beedle D, Krasuski J, Strong MJ, Sharma R, Rosen C, Viana M. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial. Biol Psychiatry. 2002 Apr 15; 51(8):659-67. PMID: 11955466.
      View in: PubMed
    16. Janicak PG, Easton MS, Comaty JE, Dowd S, Davis JM. Efficacy of ECT in Psychotic and Nonpsychotic Depression. Convuls Ther. 1989; 5(4):314-320. PMID: 11941029.
      View in: PubMed
    Dowd's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (70) concept(s)
    _
    Co-Authors Expand Description
    See all (3) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department